WASHINGTON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Epigenetics Market finds that increasing cancer rates may further expediting market growth. Primarily driven by increasing research activity and funding for Epigenetics, the total Global Epigenetics Market is estimated to reach USD 3.0 Billion by 2028.
The market stood at a revenue of USD 0.8 Billion in the year 2021, and is expected to grow at a Compound Annual Growth Rate (CAGR) of 13.1%.
Furthermore, the increasing personalized medication, and target therapy are also anticipated to augment the growth of the Global Epigenetics Market, states Vantage Market Research, in a report, titled “Epigenetics Market by Product (Instruments, Reagents & Kits, Others), by Application (Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases), by Technology (Methylation, Acetylation, Phosphorylation, Other Technologies), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)”.
Click Here To Access The Free Sample Report @ https://www.vantagemarketresearch.com/epigenetics-market-1339/request-sample
(The Free Sample Of This Report Is Readily Available On Request.)
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 130+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2021 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
- Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Vantage Market Research methodology.
(Please note that the sample of this report has been updated to include the COVID-19 impact study prior to delivery.)
List of Prominent Players in the Epigenetics Market:
- Illumina (US)
- Thermo Fisher Scientific (US)
- Merck Millipore (US)
- Abcam (UK)
- Active Motif (US)
- Bio-Rad Laboratories (US)
- New England Biolabs (US)
- Agilent (US)
- QIAGEN (Netherlands)
- Zymo Research (US)
- PerkinElmer (US)
- Diagenode (Belgium)
Market Dynamics:
Driver: Increasing Cases of Cancer to Fuel Global Epigenetics Market
A significant increase in the number of individuals suffering from cancer. WHO counts, the number of people suffering from cancer is predicted to rise to 19.3 million by 2025 from 14.1 million in 2012. Cancer is the second-highest reason for death in western countries and accounts for nearly 1 in every 4 deaths. Epigenetic modifications like the dysregulation of DNA methylation are connected to cancer development and improvement. It offers new possibilities for emanating therapeutic techniques developed to change dysregulation in cancer.
Restraint: High Cost of Apparatus to Hamper the Market Growth
Instruments required for Epigenetics analysis are pricey as they are fitted with advanced features and functionalities. Pharmaceutical companies and investigation laboratories require many such systems. Therefore, significant investments are required for procuring considerable, high-cost genomic tools. End-users such as academic analysis laboratories find it challenging to afford such practices as they have tightened budgets. High apparatus costs, therefore, hinder their wide acceptance, which is anticipated to restrict the market growth during the projected period.
Purchase This Premium Report Now @ https://www.vantagemarketresearch.com/buy-now/epigenetics-market-1339/1
Benefits of Purchasing Epigenetics Market Reports:
- Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
- Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
- Assured Quality: Focuses on accuracy and quality of reports.
- Incomparable Skills: Analysts provide in-depth insights into reports.
COVID-19 Impact Analysis:
The COVID-19 outbreak has affected various industries worldwide. Governments across the world implemented strict lockdown measures and social distancing norms in order to restrict the swift spread of the pandemic. Manufacturing facilities around the world were shut down during the initial stages of the pandemic. Moreover, the economic crisis after the pandemic might lead to a significant delay in the commercial roll-out of the industry. Small and medium-scale companies are the backbone of technology providers and are witnessing a steep drop in revenue since the emergence of the pandemic in 2020. Hence, market players faced numerous challenges as disruptions in the supply chain were observed. However, things will improve in the second half of 2022 as more supplies will come online. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data points:
- Impact Assessment of COVID-19 Pandemic
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Quarterly Market Revenue Forecast by Asia Pacific 2020 & 2021
- Key Strategies Undertaken by Companies to Tackle COVID-19
- Long Term Dynamics
- Short Term Dynamics
The report on Epigenetics Market highlights:
- Assessment of the market
- Premium Insights
- Competitive Landscape
- COVID Impact Analysis
- Historic Data, Estimates and Forecast
- Company Profiles
- Global and Regional Dynamics
Read Full Research Report @ https://www.vantagemarketresearch.com/industry-report/epigenetics-market-1339
Regional Analysis:
North America Dominates the Global Epigenetics Market
North America has dominated the Global Epigenetics Market in 2021 and is likely to continue the same trend during the forecast period. This is attributable to fast developments in the healthcare sector for cancer therapy & medication systems, and the presence of major players in the region, with huge investments made in the Research and Development (R&D) across the region. Furthermore, favourable management initiatives and the offering of funds for research are also expected to help the regional growth of the market.
Asia Pacific is likely to witness fastest growth in the Epigenetics Market during the forecast period. This is attributable to the growing medical infrastructure in economies like India, and China in the region. Further, the growing awareness among the people and increasing healthcare expenditure are also expected to help the growth of the Epigenetics Market in near future.
Recent Developments:
April, 2020: Eurofins Genomics India, a leader in genomic products and services, announces the launch of its “SARS-CoV-2 Full-length Genome Sequencing” service, a new next generation sequencing (NGS) service enabling end-to-end surveillance of the coronavirus genome sequence and mutational drift. The new service is Eurofins Genomics’ latest addition to a whole product portfolio aimed at supporting researchers in their fight against the COVID-19 pandemic.
Browse Summary of this Research Report: https://www.vantagemarketresearch.com/blog/epigenetics-865067
Key questions answered in the report:
- Which regional market will show the highest and rapid growth?
- Which are the top five players of the Epigenetics Market?
- How will the Epigenetics Market change in the upcoming six years?
- Which application and product will take a lion’s share of the Epigenetics Market?
- What is the Epigenetics market drivers and restrictions?
- What will be the CAGR and size of the Epigenetics Market throughout the forecast period?
This market titled “Epigenetics Market” will cover exclusive information in terms of Regional Analysis, Forecast, and Quantitative Data – Units, Key Market Trends, and various others as mentioned below:
| Report Attribute | Details |
| Market Size in 2021 | USD 0.8 Billion |
| Projected Market Size in 2028 | USD 3.0 Billion |
| CAGR Growth Rate | CAGR of 13.1% From 2022 - 2028 |
| Base Year | 2021 |
| Historic Years | 2016 – 2020 |
| Forecast Years | 2022 – 2028 |
| Segments Covered | Product
|
| Quantitative Data - Units | Revenue in USD Million/Billion and CAGR from 2022 to 2028 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
| Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
| Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization of the Report:
The report can be customized as per client needs or requirements. For any queries, you can contact us on sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.
Download Free Sample Report Now @ https://www.vantagemarketresearch.com/epigenetics-market-1339/request-sample
Browse More Related Report:
- Lung in Vitro Model Market:- https://www.vantagemarketresearch.com/industry-report/lung-in-vitro-model-market-1337
- Spatial Genomics and Transcriptomics Market:- https://www.vantagemarketresearch.com/industry-report/spatial-genomics-and-transcriptomics-market-1334
- Structural Biology and Molecular Modeling Market:- https://www.vantagemarketresearch.com/industry-report/structural-biology-and-molecular-modeling-market-1333
- Obesity Treatment Market:- https://www.vantagemarketresearch.com/industry-report/obesity-treatment-market-1326
About Vantage Market Research:
Vantage Market Research is a reputed company committed to providing high quality data and market research services. The company provides quantified B2B high quality research on more than 20,000 emerging markets. The company offers detailed reports on multiple industries including chemical materials and energy, food and beverages, healthcare, technology, etc. The company comprises over 125 analysts and consultants, adding more than 1,100 market research reports to its vast database every year. The company’s clientele base spans across 70% of the Global Fortune 500 companies.
Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/
Follow Us on Twitter: https://twitter.com/vantagemarketr
Contact us
Eric Kunz
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: sales@vantagemarketresearch.com
Website: https://www.vantagemarketresearch.com/
Latest Vantage Market Research Press Releases @ https://www.vantagemarketresearch.com/insight/press-releases
Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs
Blog:
- https://bwsc.kr/
- https://makitirapide.com/
- https://www.globalresearchwire.com/
- https://marketstrades.com/
- https://v-mr.biz/
